Brexit and the Healthcare Industry - Implications for Pharma, Q3 2018

2018-11-09
Price :
Published : Nov-2018
No. of Pages : 48
Table of Contents
1 Study Design
1.1 Background, Objectives, and Design
1.2 Respondent Mix - Geography
1.3 Respondent Mix - Seniority Level
1.4 Respondent Mix - Headquarters Location
2 Executive Summary
2.1 Key Findings
2.2 Change in Brexit Sentiment since Q2
3 Overview of UK Pharma Industry
3.1 The UK Pharma Industry - A Key Driver of the UK Economy
3.2 The UK as an Attractive Location for Clinical Trials
3.3 Brexit Timeline
4 Outcomes of Brexit
4.1 Best and Most Likely Outcomes of Brexit - No Brexit Is the Best Outcome but Not the Most Likely
4.2 Best and Most Likely Outcomes of Brexit - A Closer Look at Geography
5 Factors to Impact Healthcare
5.1 Key Factors to Impact the UK Healthcare Industry After Brexit
5.2 Key Factors to Impact the UK Healthcare Industry After Brexit - A Closer Look at the Top Four Factors
6 Impact on Research and Manufacturing
6.1 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? - Respondent Mix by Location
6.2 Will Healthcare Research and Manufacturing Be Impacted Following Brexit? - Respondent Mix by Seniority Level
6.3 Why the UK WILL Be an Attractive Destination for Healthcare Companies
6.4 Why the UK WILL NOT Be an Attractive Destination for Healthcare Companies
6.5 Is the UK as an Attractive Destination for Healthcare Research and Manufacturing? - In Their Words
7 Impact on Corporate Strategy
7.1 The Impact of Brexit on Corporate Strategy
7.2 The Impact of Brexit on Corporate Strategy, by Location - A Closer Look at the Numbers
7.3 The Impact of Brexit on Corporate Strategy, by Seniority Level
7.4 How Has Brexit Most Influenced Corporate Strategy? - Investing Resources into Managing the Potential Impact of Brexit Is a Major Concern
7.5 How Has Brexit Most Influenced Corporate Strategy? - In Their Words
8 Impact on Relocation
8.1 Potential of Relocation of Staff Due to Brexit - All Respondents
8.2 Potential of Relocation of Staff Due to Brexit - A Closer Look at Geography and Seniority Level
8.3 Relocation of Headquarters Unlikely After Brexit
9 Summary of Key Findings
10 Appendix
10.1 Related and Upcoming Reports
10.2 Abbreviations
10.3 Sources
10.4 About the Authors
10.5 About Thematic Research
10.6 About Thematic Reports
10.7 About GlobalData
10.8 Contact Us
10.9 Disclaimer
Filed in: Pharmaceutical
Publisher : GlobalData